共 33 条
[3]
Defining risk levels in locally advanced head and neck cancers:: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501)
[J].
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK,
2005, 27 (10)
:843-850
[5]
Hyperfractionated Accelerated Radiation Therapy (HART) of 70.6 Gy With Concurrent 5-FU/Mitomycin C Is Superior to HART of 77.6 Gy Alone in Locally Advanced Head and Neck Cancer: Long-term Results of the AR0 95-06 Randomized Phase III Trial
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2015, 91 (05)
:916-924
[6]
RADIATION THERAPY IN THE MANAGEMENT OF HEAD-AND-NECK CANCER OF UNKNOWN PRIMARY ORIGIN: HOW DOES THE ADDITION OF CONCURRENT CHEMOTHERAPY AFFECT THE THERAPEUTIC RATIO?
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2011, 81 (02)
:346-352
[10]
Flentje M., 2010, BAYER ARZTEBL, V10, P664